Our results indicate that blockade of Foxp3 failed to affect the migration of MCF7 cells but exerted a strong inhibitory effect on the migration of HER2+ LM3 and TNBC MDA-MB-231 cells, suggesting that Foxp3 may elicit differential tumor intrinsic effects depending on the tumor molecular subtype. This evidence concerns the gene ERBB2 and neoplasm.